Cargando…
Onset of vitiligo in a patient with acquired secondary hypogonadism under treatment with testosterone gel 2%: inside the pathogenesis()()
Autores principales: | Paolino, Giovanni, Bearzi, Pietro, Mercuri, Santo Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563011/ https://www.ncbi.nlm.nih.gov/pubmed/32713727 http://dx.doi.org/10.1016/j.abd.2020.02.010 |
Ejemplares similares
-
Late-onset hypogonadism: beyond testosterone
por: Foresta, Carlo, et al.
Publicado: (2015) -
Safety and efficacy of testosterone gel in the treatment of male hypogonadism
por: Lakshman, Kishore M, et al.
Publicado: (2009) -
Commentary on “Late-onset hypogonadism - beyond testosterone”
por: Hackett, Geoffrey
Publicado: (2015) -
Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Pontara, Andrea, et al.
Publicado: (2020) -
Pilot Study on the Use of the “Monocyte-Rich” Platelet-Rich Plasma in Combination with 1927 nm Fractional and 308 nm Excimer Lasers for the Treatment of Vitiligo
por: Mercuri, Santo Raffaele, et al.
Publicado: (2021)